Superworth

Maxcyte shares outstanding MXCT

Diluted shares outstanding, averaged over each quarter, from 2020.

Latest quarter, to Jun 30, 2026
106.8M
On a year earlier
+0.4%
more shares

Maxcyte had 106.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.

That is about the same as a year earlier.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY2025106.7M+1%
FY2024105.5M+2%
FY2023103.7M+2%
FY2022102.1M+1%
FY2021100.8M+30%
FY202077.4Mn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY26106.8M+0%
Q1 FY26106.9M+1%
Q4 FY25106.7M+1%
Q3 FY25106.6M+1%
Q2 FY25106.4M+2%
Q1 FY25106M+2%
Q4 FY24105.5M+2%
Q3 FY24105.1M+2%
Q2 FY24104.6M+2%
Q1 FY24104.1M+1%
Q4 FY23103.7M+2%
Q3 FY23103.4M+2%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Maxcyte

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.